ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 408,64
-0,30%
Dow Jones
42 297,12
0,86%
DAX
20 132,85
-0,44%
Brent Oil
80,28
0,00%
Bitcoin
94 408,77
-0,11%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Dyne Therapeutics Inc (DYN) Cours

Dyne Therapeutics Inc

Dyne Therapeutics Inc (DYN)

NASDAQ
15,29
-0,58
(-3,65%)
À la fermeture: 14 Janvier 10:00PM
Retardé de 15 minutes
15,63
0,34
( 2,22% )
Après les heures de négociation: 10:30PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
15,63
Prix Achat
15,29
Prix Vente
15,80
Volume échangé
2 950 943
14,845 Fourchette du Jour 15,80
14,7923 Plage de 52 semaines 47,45
Cap du marché
1,591B
Clôture Veille
15,87
Ouverture
15,80
Dernière Transaction
5
@
15.8
Dernière heure de transaction
23:13:43
Volume financier
US$ 44 923 495
VWAP
15,2234
Volume moyen (3 m)
1 105 857
Actions en circulation
101 765 958
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,59
Bénéfice par action (BPA)
-2,32
Chiffre d'affairess
-
Bénéfice net
-235,94M

À propos de Dyne Therapeutics Inc

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.dyne-tx.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Dyne Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker DYN. Le dernier cours de clôture d'Dyne Therapeutics était de US$15,87. Au cours de la dernière année, les actions de Dyne Therapeutics ont été négociées dans une fourchette de prix de US$ 14,7923 à US$ 47,45.

Dyne Therapeutics compte actuellement 101 765 958 actions en circulation. La capitalisation boursière d'Dyne Therapeutics est de US$1,62 milliard. Dyne Therapeutics a un ratio cours/bénéfice (ratio PE) de -6.59.

Flux d'options Dyne Therapeutics (DYN)

Voir le flux d'options complet

Flux global

Baissier

Prime nette

-2M

Calls / Puts

0,00%

Ach. / Vent.

1 800,00%

OTM / ITM

0,00%

Sweeps Ratio

0,00%

DYN Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

10 Janvier 2025
Edgar (US Regulatory)

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101

- DYNE-101 in DM1: Dyne plans to initiate global Registrational Expansion Cohort of ACHIEVE trial with registrational dose of 6.8 mg/kg Q8W following study data showing splicing correction and...

10 Janvier 2025
GlobeNewswire Inc.

Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...

09 Janvier 2025
GlobeNewswire Inc.

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...

08 Janvier 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

12 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

11 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-9.08-36.746256576324.7124.9814.7923314219517.63081034CS
4-10.03-39.088074824625.6626.53514.7923147198621.03396901CS
12-19.19-55.112004595134.8235.6814.7923110585726.17777802CS
26-25.59-62.081513828241.2247.4514.7923116646432.69859514CS
52-0.75-4.5787545787516.3847.4514.7923124718530.06960178CS
1565.5454.905847373610.0947.454.373271322.32769453CS
260-7.82-33.347547974423.4547.454.359236521.75555487CS

DYN - Frequently Asked Questions (FAQ)

What is the current Dyne Therapeutics share price?
The current share price of Dyne Therapeutics is US$ 15,63
How many Dyne Therapeutics shares are in issue?
Dyne Therapeutics has 101 765 958 shares in issue
What is the market cap of Dyne Therapeutics?
The market capitalisation of Dyne Therapeutics is USD 1,62B
What is the 1 year trading range for Dyne Therapeutics share price?
Dyne Therapeutics has traded in the range of US$ 14,7923 to US$ 47,45 during the past year
What is the PE ratio of Dyne Therapeutics?
The price to earnings ratio of Dyne Therapeutics is -6,59
What is the reporting currency for Dyne Therapeutics?
Dyne Therapeutics reports financial results in USD
What is the latest annual profit for Dyne Therapeutics?
The latest annual profit of Dyne Therapeutics is USD -235,94M
What is the registered address of Dyne Therapeutics?
The registered address for Dyne Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Dyne Therapeutics website address?
The website address for Dyne Therapeutics is www.dyne-tx.com
Which industry sector does Dyne Therapeutics operate in?
Dyne Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
YOSHYoshiharu Global Company
US$ 4,21
(46,18%)
79,75k
MNDRMobile health Network Solutions
US$ 0,58
(42,79%)
16,64M
STAFStaffing 360 Solutions Inc
US$ 3,20
(40,66%)
2,09M
PIIIP3 Partners Inc
US$ 0,2589
(20,47%)
10,44M
AREBAmerican Rebel Holdings Inc
US$ 2,53
(17,67%)
216,64k
ATPCAgape ATP Corporation
US$ 1,58
(-19,80%)
512,03k
GCTKGlucoTrack Inc
US$ 0,122
(-18,50%)
18,83M
CHEKCheck Cap Ltd
US$ 1,25
(-16,67%)
69,27k
AEHRAehr Test Systems
US$ 13,50
(-15,57%)
787,01k
GRNQGreenpro Capital Corporation
US$ 1,11
(-12,60%)
49,9k
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0681
(8,27%)
23,11M
GCTKGlucoTrack Inc
US$ 0,122
(-18,50%)
18,83M
MNDRMobile health Network Solutions
US$ 0,58
(42,79%)
16,64M
LAESSEALSQ Corporation
US$ 3,02
(-9,85%)
12,03M
PIIIP3 Partners Inc
US$ 0,2589
(20,47%)
10,44M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
DYN
Dyne Therapeutics
AQSE
CAD.GB
Cadogan Energy Solutions
NASDAQ
FMXPBX
Convertible & Income Sel...
UPBT
TIXETH
Blocktix
BIT
UB4Q9U
Unicredit Bank
BIT
UC27QX
Unicredit Bank
BOV
GGPS3
GPS Participacoes e Empr... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés